Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity DrugBy Press Room12 May 2025 Tens of thousands of Americans will soon be forced by their heath insurance to switch from one popular obesity drug…
Weight Loss Drug Will Be Offered for $499 a Month for Some PatientsBy Press Room6 March 2025 Novo Nordisk will cut the price of its blockbuster weight loss medication Wegovy to $499 per month for certain patients…
Novo Nordisk Annual Sales Jump on Demand for Ozempic and WegovyBy Press Room5 February 2025 Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, capped off a somewhat turbulent 2024, reporting profit and revenue…